Home / Clinics / Sexual Wellness / Women's Sexual Wellness
Open a Women's Sexual Wellness Clinic
The Most Underserved Patient in Cash-Pay Health.
Women in this category have usually been dismissed at least once before they walk through your door. The clinic that takes the conversation seriously does not just win the visit, it wins the next decade of that patient's care. The category is growing faster than the men's side and has a fraction of the competition.
Book a Strategy CallWhat the Numbers Actually Show
The clinical treatment market for female sexual dysfunction is estimated at roughly $600 million in 2026, projected to reach about $1.66 billion by 2034 at a compound annual growth rate near 13.6 percent. North America accounts for close to 89 percent of it, which is an unusually concentrated share.
Now hold that next to the broader picture. The wider sexual wellness market is measured in the tens of billions, women represent roughly 70 percent of it, and the women's segment is growing faster than the men's. So consumer demand is enormous and clinical supply is small.
That gap is the entire opportunity, and it is not subtle. Compare the growth rates: this category is compounding at roughly 13 percent while the men's side sits closer to 3 to 7 percent depending on whose definition you use. Demand is moving faster here, and far fewer operators are building for it.
The women's category is not underserved because the demand is not there. It is underserved because most operators default to the men's model and never look at the other half of the market.
Sources: Fortune Business Insights and Roots Analysis, 2026. Estimates vary by market definition. Local demand varies by market.
What a Women's Sexual Health Clinic Actually Offers Patients
The service menu below reflects how clinics in this category are commonly structured. It is a description of a business model, not a statement of clinical outcomes, and nothing here is a claim about what any treatment does for any patient. Those determinations belong to your Medical Director and to the evidence.
The anchor service line for most clinics in this category. Perimenopause and menopause care overlaps heavily with sexual health concerns, and the two feed each other. See our Women's Health and Hormones clinic model.
Platelet-rich plasma drawn and returned to the same patient in a single visit. Several branded protocol names in this space are registered trademarks and require training and licensing to use by name.
Comprehensive lab work and structured intake. In a category where patients have often been dismissed elsewhere, thorough workup is both the clinical standard and the trust-builder.
Widely marketed in this category and the single biggest compliance exposure in it. Read the regulatory section below before you build any service line on these. This is not optional reading.
Pelvic floor physical therapy and specialist referral relationships. Many operators build these partnerships rather than bringing the service fully in-house.
Often positioned inside a broader women's health practice with biomarker panels, nutrition, and IV therapy. Extends patient value well beyond the initial concern.
Consultation and follow-up delivered remotely, which suits a patient population that values privacy and flexibility. Cross-state prescribing rules apply and vary.
Every protocol, device selection, and prescribing decision runs through a licensed physician. ACG introduces clients to vetted Medical Directors across all 50 states.
The Device Warning Most Operators Have Never Read
On July 30, 2018, the FDA issued a safety communication on energy-based devices marketed for vaginal cosmetic procedures. Its position was direct: the agency has not cleared or approved any energy-based device for these procedures, or for symptoms related to menopause, urinary incontinence, or sexual function, and the safety and effectiveness of such use has not been established.
The FDA sent warning letters to seven device manufacturers over how these products were being marketed. Those companies make equipment that is still actively sold into clinics today.
Understand what that means for you as an owner. A device rep can show you a 510(k) clearance that is entirely real, and that clearance may be for a general gynecological indication that has nothing to do with what the marketing materials imply. The clinic making the claim carries the exposure, not the manufacturer who supplied the brochure.
Nobody selling you a women's health clinic build is going to open with this. We do, because the operators who get this wrong find out from a regulator instead of from a consultant.
Not the brochure, not the rep's summary. The actual clearance, and the exact indication it covers. ACG helps you ask for it and read what it does and does not authorize.
The FDA noted the term is not clearly defined, and it sits at the center of the enforcement history. ACG builds service and marketing language that describes what you offer without inheriting that exposure.
The moment that copy appears on your site, it is your claim to defend. ACG's marketing audit reviews every service description against what your products are actually authorized to be marketed for.
Hormone care, diagnostics, and autologous procedures sit in a very different posture than energy-based devices used off-label. Sequence the build accordingly.
Structured intake and genuine informed consent are what protect the practice if a claim is ever questioned. In this category especially, that record is your defense.
Protocols, device selection, and patient consent are reviewed and formally approved by a licensed physician before first patient. ACG coordinates that relationship across all 50 states.
Why This Patient Becomes a Lifetime Client
This is a cash-pay category. Insurance coverage in this space is inconsistent at best, which removes billing cycles and reimbursement negotiation. Patients pay at the point of service.
The retention dynamic here is different from most of health, and it is worth understanding properly. A woman who has been brushed off by two or three providers and then finds a practice that listens does not treat that as a transaction. She comes back for hormone care, for menopause management, for longevity services, and she tells other women. Referral behavior in this category is unusually strong.
Cash-Pay
No reimbursement cycles and no payer margin erosion on the core service lines.
Required
ACG coordinates the clinical infrastructure. You own and operate the business.
Launched
Across all 50 states, over 30+ years of combined operational history.
Launch Window
From keys received, market and regulatory conditions permitting.
Answers Before
You Open.
This category has a specific regulatory history that most operators entering it have never read. The answers below are direct, including the uncomfortable ones.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsCan I offer laser or radiofrequency treatments in this category?
Why do you tell operators to avoid the word "rejuvenation"?
Do I need to be a physician to own this clinic?
How does this pair with a hormone or menopause practice?
Why is this category less competitive than the men's side?
Can I advertise this clinic on Meta and Google?
Are the branded procedure names free to use?
What revenue per patient is realistic?
Half the Market.
A Fraction of the Competition.
Book a free 30-minute strategy call. ACG will walk you through the opportunity in your specific market, the device and claims picture, the acquisition strategy, and what the process looks like from first conversation to open doors.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time